INTRODUCTION
The disorder, congenital galactosemia, characterized by cataracts, liver disease, and mental retardation, is due to a deficiency of the enzyme galactose-l-phosphate uridyl transferase (UDPglucose:' a-n-galactose-l-P uridyl transferase [Enzyme Commission, 2.7.7.12]) (1) . This Received for publication 27 August 1970 and in revised form 6 November 1970. 1Abbreviations used in this paper: UTP, uridine triphosphate; UDPG, TDPG, CDPG, UDPGal, nucleotide sugars. enzyme which catalyzes the reaction gal-l-P + UDPglucose -4 glucose-l-P + UDPgalactose has been shown to be defective in a variety of tissues from galactosemic patients, and has been studied from a kinetic point of view in human erythrocytes (2) , leucocytes (3, 4), cultured fibroblasts (4) , and most recently, intestinal mucosa (5) . Although the liver is the principle tissue for disposal of galactose, and despite the fact that the defect has been demonstrated in liver (6) , there has been no detailed kinetic characterization of human liver transferase nor further exploration of the enzyme activity in liver of galactosemic patients.
Of particular interest has been the group of patients with congenital galactosemia who despite absent red cell gal-i-P uridyl transferase, has been shown to metabolize significant amounts of galactose (7, 8) . Since all of these patients have been Negro, the term "Negro variant" of galactosemia has been applied to this group (9) . Of several tissues from such a patient studied in vitro, only liver has been shown to oxidize galactose-l-"4C to 'CO2 (10) . In order to determine whether this oxidation is related to the presence of residual galactose-l-P uridyl transferase activity, we have assessed the level of this enzyme in liver biopsies from galactosemic Negroes and Caucasians after first characterizing the kinetic properties of the enzyme in liver of nongalactosemic subjects. Our results form the basis of this report.
METHODS
Subjects. Pertinent clinical data on subjects from whom liver biopsies were obtained are summarized in Table I . Six patients ranging in age from 4 months to 41 yr and without any history or stigmata of deranged galactose metabolism are considered control subj ects. Specimens were obtained from two controls by punch needle biopsy (C with idiopathic hypoglycemia and K who had cystinosis with a considerable degree of renal failure). Of the other four patients from whom small wedge biopsies were surgically ob- (8) . In more recent metabolic studies, these brothers both demonstrated substantial ability to metabolize small amounts of galactose-l-"C to "CO2 and belong in the group termed the "Negro variant" of subjects with galactosemia (9) . Previously, liver tissue from patient W. W. had been shown in vitro to oxidize radioactive galactose to "CO2 (8) . The Handling of tissue and assay of Gal-i-P uridyl transferase.
Punch biopsies weighing between 25 and 35 mg and wedge biopsies weighing about 20 mg were kept at 4°C for 10-20 min until homogenized in 20 vol of 20 mm KCl. After spinning at 30,000 g for 30 min the supernatant was divided into 0.1 ml aliquots which were frozen in glass vials and kept at -44°C until used. The homogenate enzyme activity was stable on storage at -44°C for 6 months.
Liver obtained at autopsy was frozen and stored at -44°C until partially purified with minor modifications by the method of Mayes and Hanson (11) . The steps consisted of homogenization in 20 mm KCl, precipitation with ammonium sulfate at 50% saturation, dialysis against distilled water, adsorption and elution from calcium phosphate gel, and chromatography of the gel eluate on a DEAE-cellulose column employing elution with batches of 20 and 80 mM phosphate buffer. The specific activity of the enzyme before and after purification is shown in Table I .
The determination of enzyme activity was performed by the method of Bertoli and Segal (12) except that the alkaline phosphatase step 'was not used prior to chromatography of the incubation mixture. The assay is based on the stoichiometric formation of UDPgalactose-"C during the incubation of the enzyme with galactose-l-P-"'C and unlabeled UDPG according to the reaction Gal-l-P-"C + UDPG -4 UDPGal-'C + G-l-P. After incubation the labeled gal-l-P is separated from the radioactive product by chromatography on DEAE-cellulose ion exchange paper with 0.05 M LiCl as solvent. The product radioactivity was determined by counting the area of the paper containing the UDPgalactose-1'C with a liquid scintillation spectrometer employing Liquifluor (New England Nuclear Corp., Boston, Mass.) as the scintillator. The amount of product formed can be calculated using the specific activity of the radioactive substrate.
Human Liver Galactose-1-Phosphate Uridyl Transferase Other assay procedures. UDPgalactose pyrophosphorylase was assayed both by the technique of Abraham and Howell (13) and by the standard procedure reported here for transferase except that 0.25 mm UTP was added as substrate in place of UDPG. Protein was estimated by the method of Lowry, Rosebrough, Tarr, and Randall (14 Transferase activity measured in the pH range from 8 to 9 revealed a broad optimum between 8.2 and 8.6 for the purified preparation (Fig. 3) . Essentially the same results were found with crude homogenate.
The relationship of substrate concentration to enzyme activity is shown in Fig. 4 by a typical Lineweaver-Burk plot of the data obtained with both whole homogenate and purified enzyme. Table II summarizes the Km and Vmax values for UDPG when Gal-l-P was 0.25 mm and for Gal-l-P when UDPG was 0.20 mm for the various enzyme preparations studied. Km values were relatively uniform in both homogenates and purified preparation. Vra. in the various homogenates was similar except for subject R who had been given actinomycin D. The difference in maximum velocity for purified and crude enzyme reflects the approximately 50-fold purification obtained.
Various nucleotide sugars such as TDPG, CDPG, and UDPGal were tested at 0.20 mm as substrates in place of UDPG for reaction with labeled Gal-l-P. In our standard incubation only UDPGal resulted in a labeled compound migrating as a sugar nucleotide on DEAE paper chromatography. The velocity of this reaction, Gal-l-P-w"C + UDPGal > UDPGal-14C + Gal-l-P, was concentration dependent as shown in Fig. 5 . The Km and Vmra of UDPGal when Gal-l-P was 0.25 mm are shown in Table II (6) . Until recently their data seemed sufficient for interpreting the metabolic derangement in galactosemic patients. The demonstration that certain galactosemic patients with absent red cell transferase can metabolize administered galactose (7) has prompted a reinvestigation of liver transferase activity in both normals and galactosemic patients. In the present work, we have analyzed in detail the kinetic parameters of transferase from the livers of nongalactosemic controls and have shown the similarities of partially purified enzyme to biopsy homogenates.
The characteristics of transferase activity in normal human liver are similar to those observed previously with rat liver (12) .
Our values for liver transferase differ from those of
Anderson et al. whose data until now were the only data available about the human enzyme (6) . Although the radioactive assay used was similar in principle to that described here, no kinetic analysis of the conditions for the assay was reported. Comparison of the transferase activity in liver of four galactosemic subjects with that of nongalactosemic controls has revealed that two galactosemic patients, Negro siblings, possess easily detectable amounts of enzyme in liver amounting to 10% of the normal, while two Caucasian with galactosemia had nondetectable levels (that is, less than 1-2% of the normal). Of the two liver homogenates assayed by Anderson et al. (6) , one was an adult Negro male who had easily detectable enzyme activity while the other was a Caucasian infant without detectable enzyme.' The latter investigators felt that the finding of detectable enzyme in the Negro adult was related to his older age. Subsequent studies have indicated that being a Negro may be a factor in the ability of galactosemic patients to metabolize galactose (7, 9) .
Enzyme activity would not be expected to "mature" with age since developmental studies of rat liver transferase have indicated that transferase has the highest specific activity in the young liver and subsequently decreases with age (12) .
The Negro adult who had detectable enzyme estimated at 5% of normal (6), was later extensively studied for his metabolic capability and was found to be able to easily metabolize galactose-l-"4C to 14CO2 (7, 9 'Although the race of the patients was not stated in the paper by Anderson, Kalckar, and Isselbacher, the race of the adult is known by one of the authors, who was at National Institutes of Health at the time, and who subsequently studied the same patient (7) . The race of the infant was made known to the present authors by Dr. George Donnell of the Los Angeles Childrens Hospital, who sent the biopsy to Dr. Kalckar. punch liver biopsy at that time was capable in vitro of galactose oxidation (8) . The ability of both Negro patients W. W. and M. W. to oxidize galactose-l-"C was tested at the time of the liver biopsy for transferase activity and both were found able to rapidly and extensively convert the radioactive substrate to 14CO2. The observations that Negro galactosemic patients convert galactosel-'4C to blood glucose (7), have inhibition of galactose oxidation by ethanol (7, 16) , and produce '4CO2 from both C-1 and C-2 labeled galactose in a normal pattern (17) , are consistent with operation of the sugar nucleotide pathway of galactose metabolism. The findings that Negroes with galactosemia have residual transferase in the liver imply that it is this enzyme, though limited in amount, which accounts for their ability to metabolize galactose. This is consistent with our observations that the capacity of the Negro galactosemic to metabolize intravenously administered galactose is limited, being nearly normal for quantities up to only 2 g (7).
An alternate pathway involving a nucleotide sugar as an explanation of the galactosemic Negro's ability to metabolize galactose could be considered. The UDPGal pyrophosphorylase reaction in which Gal-l-P + UTP UDPGal + PP was postulated by Isselbacher to serve this function (15) . Such a reaction would circumvent the transferase step and satisfy the metabolic observations enumerated earlier. Recently, Abraham and Howell studied this enzyme activity in autopsy specimens of human liver (13) . Employing a standardized assay, they showed that the specific activity of the enzyme was about one hundredth that of Gal-l-P uridyl transferase, there being no increase with age as suggested by Isselbacher's rat experiments (15) . Indeed, the activity is so low as to raise the question of its functional significance. Knop and Hanson, who studied the substrate specificity of human liver crystalline UDPglucose pyrophosphorylase, reported that what has been called UDPGal pyrophosphorylase activity is in reality a small degree of reactivity of UDPG pyrophosphorylase with UDPGal (18). Ting and Hanson have suggested caution in attributing significance to the pyrophosphorylase route for metabolism of galactose (19) . Nonetheless, we have looked for this activity in our biopsies of galactosemic and normal subjects. In short incubation times during which transferase is very active in normal subjects and easily detectable in galactosemic Negroes, no UDPGal pyrophosphorylase activity was seen. It is our feeling that UDPGal pyrophosphorylase activity is unlikely to explain the rapid and quite proficient galactose metabolism seen in Negroes with galactosemia. Likewise, we have observed no other transferase activity employing another sugar nucleotide such as TDPG that might adequately explain the metabolic observations.
The delineation of a difference between Negro and Caucasian patients with galactosemia by the presence or absence of liver transferase activity, appears to be paralleled by similar finding with intestinal mucosa (5) .
About 10% of the normal intestinal Gal-l-P uridyl transferase was found to exist in mucosal biopsies from three Negroes with galactosemia, two of whom are subjects in the present paper. This would appear to reflect the common embryonic origin of the two tissues. The exact contribution of gastrointestinal tissue to the disposition of galactose, however, in the normal individual is not known. Although the liver is thought to be the prime organ for normal galactose disposal, it may well be that the liver and intestinal mucosa together provide the transferase complement which enables the galactosemic Negro to metabolize some galactose. The exact explanation for possession of transferase activity by visceral tissue when other tissues of the Negro patients are deficient, remains to be explained. 6 Negroes are in the group of 18 subjects with galactosemia that we have studied. All five of the six who have been tested have metabolized galactose to a significant degree. In Hsia's group of 45 patients (20) , two siblings are identified as Negroes, one of whom has been without symptoms of galactose toxicity while ingesting galactose (resembling our patient W. W.). Donnell's clinic of 41 subjects with galactosemia includes two Negroes (21) . None of the patients in the latter two groups has had a quantitation of galactose metabolism but there is a clinical indication that the Negro in Hsia's group has a galactose metabolic capability. Although there appears to be a racial correlation with an ability Human Liver Galactose-1-Phosphate Uridyl Transferase 
